SBHMY.US Sino Biopharmaceutical Ltd ADR

Healthcare Biotechnology USA Stocks
14.40 USD
Close of Nov 17, 2026
10.98 17.80
Market cap
USD 12.8B
P/E
37.9x
P/B
2.62x
ROE
21.1%
Dividend yield
2.13%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is SBHMY.US undervalued?

Graham number
Price14.40
Graham value6.85
Premium110.2%

SBHMY.US trades 110.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sino Biopharmaceutical Ltd ADR fundamental analysis

No fundamental analysis for Sino Biopharmaceutical Ltd ADR yet.

Sino Biopharmaceutical Ltd ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sino Biopharmaceutical Ltd ADR

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, ben…

Full company profile